Covid-19 pandemic: Covovax data with DCGI, approval expected soon

India has said any vaccine that has approval from stringent regulatory bodies like the USFDA, UK-MHRA, etc., will be approved for use in India

Approval for Serum Institute of India- (SII-) manufactured Covovax, the Indian version of US major Novavax’s protein sub-unit Covid-19 vaccine, is expected anytime. Sources said the nod may even come as early as December-end after the world’s top health body and the European Medicines Agency (EMA) gave their thumbs up to the vaccine recently.

“Data from the Indian arm of the trials have been submitted and the review is on. With the World Health Organisation (WHO) and EMA giving their nods, the process of approval in India becomes that much easier,” said a source.

Adar Poonawalla, CEO of SII had earlier indicated